Calls Purchased on Teva Pharmaceutical (TEVA)

Shares of Teva Pharmaceutical Industries LTD (NASDAQ:

) are lower on the session by 1.70%, currently trading at $51.15. The stock has been running largely lower over the past three months and is now trading below both the 50-day and 200-day moving averages. Options traders are betting on a recovery today and call volume is rising. The September $60 call was purchased 2,000 times at the opening bell; open interest on the strike is 15,964 contracts. There have also been several hundred lots bought out in January of 2011 on the $65, 67.50, and 70 strikes. Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson's disease, respiratory products and women's health products. You Can't Afford Miss Out On These Trading